These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 10874881)
1. Usefulness of CD79b expression in the diagnosis of B-cell chronic lymphoproliferative disorders. McCarron KF; Hammel JP; Hsi ED Am J Clin Pathol; 2000 Jun; 113(6):805-13. PubMed ID: 10874881 [TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders. Cabezudo E; Carrara P; Morilla R; Matutes E Haematologica; 1999 May; 84(5):413-8. PubMed ID: 10329919 [TBL] [Abstract][Full Text] [Related]
3. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation. Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686 [TBL] [Abstract][Full Text] [Related]
4. Heterogeneous intracellular expression of B-cell receptor components in B-cell chronic lymphocytic leukaemia (B-CLL) cells and effects of CD79b gene transfer on surface immunoglobulin levels in a B-CLL-derived cell line. Minuzzo S; Indraccolo S; Tosello V; Piovan E; Cabrelle A; Trentin L; Semenzato G; Amadori A Br J Haematol; 2005 Sep; 130(6):878-89. PubMed ID: 16156858 [TBL] [Abstract][Full Text] [Related]
5. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment. Kusenda J; Babusíková O Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418 [TBL] [Abstract][Full Text] [Related]
6. A novel scoring system combining expression of CD23, CD20, and CD38 with platelet count predicts for the presence of the t(11;14) translocation of mantle cell lymphoma. Medd PG; Clark N; Leyden K; Turner S; Strefford JA; Butler C; Collins GP; Roberts DJ; Atoyebi W; Hatton CS Cytometry B Clin Cytom; 2011; 80(4):230-7. PubMed ID: 21462308 [TBL] [Abstract][Full Text] [Related]
7. Typical and atypical chronic lymphocytic leukemia differ clinically and immunophenotypically. Frater JL; McCarron KF; Hammel JP; Shapiro JL; Miller ML; Tubbs RR; Pettay J; Hsi ED Am J Clin Pathol; 2001 Nov; 116(5):655-64. PubMed ID: 11710681 [TBL] [Abstract][Full Text] [Related]
8. Pan B-cell markers are not redundant in analysis of chronic lymphocytic leukemia (CLL). Monaghan SA; Peterson LC; James C; Marszalek L; Khoong A; Bachta DJ; Karpus WJ; Goolsby CL Cytometry B Clin Cytom; 2003 Nov; 56(1):30-42. PubMed ID: 14582135 [TBL] [Abstract][Full Text] [Related]
9. Clinical utility of flow cytometry in the chronic lymphoid leukemias. DiGiuseppe JA; Borowitz MJ Semin Oncol; 1998 Feb; 25(1):6-10. PubMed ID: 9482521 [TBL] [Abstract][Full Text] [Related]
10. A scoring system based on the expression of six surface molecules allows the identification of three prognostic risk groups in B-cell chronic lymphocytic leukemia. Zucchetto A; Bomben R; Dal Bo M; Sonego P; Nanni P; Rupolo M; Bulian P; Dal Maso L; Del Poeta G; Del Principe MI; Degan M; Gattei V J Cell Physiol; 2006 May; 207(2):354-63. PubMed ID: 16331666 [TBL] [Abstract][Full Text] [Related]
11. Flow cytometric immunophenotyping analysis of patterns of antigen expression in non-Hodgkin's B cell lymphoma in samples obtained from different anatomic sites. Gervasi F; Lo Verso R; Giambanco C; Cardinale G; Tomaselli C; Pagnucco G Ann N Y Acad Sci; 2004 Dec; 1028():457-62. PubMed ID: 15650271 [TBL] [Abstract][Full Text] [Related]
12. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases]. Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665 [TBL] [Abstract][Full Text] [Related]
13. CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia. Palumbo GA; Parrinello N; Fargione G; Cardillo K; Chiarenza A; Berretta S; Conticello C; Villari L; Di Raimondo F Leuk Res; 2009 Sep; 33(9):1212-6. PubMed ID: 19230971 [TBL] [Abstract][Full Text] [Related]
14. The cut-off levels of CD23 expression in the differential diagnosis of MCL and CLL. Barna G; Reiniger L; Tátrai P; Kopper L; Matolcsy A Hematol Oncol; 2008 Sep; 26(3):167-70. PubMed ID: 18381689 [TBL] [Abstract][Full Text] [Related]
15. CD200 expression in B-cell chronic lymphoproliferative disorders. El Desoukey NA; Afify RA; Amin DG; Mohammed RF J Investig Med; 2012 Jan; 60(1):56-61. PubMed ID: 22064604 [TBL] [Abstract][Full Text] [Related]
16. [Density expression of the CD20 antigen on population of tumor cells in patients with chronic B-lymphocyte lymphoproliferative diseases]. Suková V; Klabusay M; Coupek P; Brychtová Y; Doubek M; Mayer J Cas Lek Cesk; 2006; 145(9):712-6; discussion 716-7. PubMed ID: 17091727 [TBL] [Abstract][Full Text] [Related]
17. Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentation. Nelson BP; Variakojis D; Peterson LC Mod Pathol; 2002 Nov; 15(11):1111-20. PubMed ID: 12429788 [TBL] [Abstract][Full Text] [Related]
18. Value of CD23 determination by flow cytometry in differentiating mantle cell lymphoma from chronic lymphocytic leukemia/small lymphocytic lymphoma. Gong JZ; Lagoo AS; Peters D; Horvatinovich J; Benz P; Buckley PJ Am J Clin Pathol; 2001 Dec; 116(6):893-7. PubMed ID: 11764079 [TBL] [Abstract][Full Text] [Related]